About Talking Medicines
Talking Medicines is a company based in Glasgow (United Kingdom) founded in 2013.. Talking Medicines has raised $4.37 million across 5 funding rounds from investors including Scottish Enterprise, Tern and Mark Bamforth. The company has 34 employees as of January 31, 2022. Talking Medicines offers products and services including Drug-GPT, Message Alignment, Persona Development, and Audience Intelligence. Talking Medicines operates in a competitive market with competitors including Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others.
- Headquarter Glasgow, United Kingdom
- Employees 34 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Talking Medicines Limited
- Date of Incorporation 10 Apr, 2013
- Jurisdiction GLASGOW, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.37 M (USD)
in 5 rounds
-
Latest Funding Round
$2.14 M (USD), Seed
Feb 01, 2022
-
Investors
Scottish Enterprise
& 4 more
-
Employee Count
34
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Talking Medicines
Talking Medicines offers a comprehensive portfolio of products and services, including Drug-GPT, Message Alignment, Persona Development, and Audience Intelligence. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for conversational data analysis in healthcare marketing.
Service to identify alignment in healthcare statements and track ROI.
Platform for analyzing author characteristics in healthcare data.
Tool for gaining 360-degree views on healthcare subpopulations.
Unlock access to complete
Unlock access to complete
Funding Insights of Talking Medicines
Talking Medicines has successfully raised a total of $4.37M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $2.14 million completed in February 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $2.1M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2022 | Amount | Seed - Talking Medicines | Valuation |
investors |
|
| Nov, 2020 | Amount | Seed - Talking Medicines | Valuation | Tern | |
| May, 2019 | Amount | Seed - Talking Medicines | Valuation | SIS Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Talking Medicines
Talking Medicines has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Scottish Enterprise, Tern and Mark Bamforth. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in IoT companies are managed by Tern.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on social impact companies
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Talking Medicines
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Talking Medicines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Talking Medicines Comparisons
Competitors of Talking Medicines
Talking Medicines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provides AI and cloud-based platform for doctors for patient engagement and care
|
|
| domain | founded_year | HQ Location |
Cloud-based medication management software is provided for healthcare providers.
|
|
| domain | founded_year | HQ Location |
Prescription drugs refill management solutions
|
|
| domain | founded_year | HQ Location |
Medication management systems are supplied to healthcare providers and pharmacies.
|
|
| domain | founded_year | HQ Location |
Devices and apps for medication adherence are provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based medication adherence monitoring is provided for healthcare providers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Talking Medicines
Frequently Asked Questions about Talking Medicines
When was Talking Medicines founded?
Talking Medicines was founded in 2013 and raised its 1st funding round 4 years after it was founded.
Where is Talking Medicines located?
Talking Medicines is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Is Talking Medicines a funded company?
Talking Medicines is a funded company, having raised a total of $4.37M across 5 funding rounds to date. The company's 1st funding round was a Seed of $808.62K, raised on Aug 28, 2017.
How many employees does Talking Medicines have?
As of Jan 31, 2022, the latest employee count at Talking Medicines is 34.
What does Talking Medicines do?
Talking Medicines was founded in 2013 in Glasgow, United Kingdom. Operations focus on the healthcare marketing sector, where an AI-powered platform is utilized to deliver structured intelligence from unstructured data via a natural language interface. Machine learning, natural language processing, and domain-specific knowledge are employed to analyze text inputs. Services include message alignment, persona development, and audience intelligence for marketing applications.
Who are the top competitors of Talking Medicines?
Talking Medicines's top competitors include Wellth, Phil and Capsa Healthcare.
What products or services does Talking Medicines offer?
Talking Medicines offers Drug-GPT, Message Alignment, Persona Development, and Audience Intelligence.
Who are Talking Medicines's investors?
Talking Medicines has 5 investors. Key investors include Scottish Enterprise, Tern, Mark Bamforth, Scottish Investment Bank, and SIS Ventures.